Patients who may benefit from discussing LDN with a Provn provider include: Those with significant needle anxiety that GLP-1 therapy would compound Those with a history of pancreatitis or other GLP-1 contraindications Those with autoimmune conditions who havent responded to conventional weight management approaches Those experiencing chronic inflammation that may contribute to metabolic difficulty Those who have tried GLP-1 therapy without success or with intolerable side effects LDN is taken as a daily oral capsule at bedtime, avoiding the storage, injection, and travel logistics associated with GLP-1 injectable therapy
GLP-1 agonists showed effects on reward responses during anticipation and consumption of food rewards in lean participants (caudate, OFC), in participants with obesity (OFC) and in participants with T2D (putamen, insula, amygdala) (van Bloemendaal et al., 2015a)
13,16,19,20 What causes rosacea flare-ups
Martinek, T
Give it four more weeks : Plateaus often break on their own once your body settles into a new equilibrium
The LEADER trial with liraglutide reported a reduction in MACE (HR 0.87), while the REWIND trial with dulaglutide demonstrated an HR of 0.88